Shares of Teladoc Health (NYSE: TDOC) have more than doubled in 2020 and analysts tasked with watching the telehealth pioneer are confidently predicting more gains ahead. Ahead of Teladoc's third-quarter earnings call, Sean Wieland at Piper Sandler raised his price target for Teladoc to $305, a 42% gain over the stock's recent price.
Teladoc Health stock dipped during Thursday's trading session despite a positive vote to join forces with Livongo Health (NASDAQ: LVGO) . Here are four of the biggest reasons investors can be confident about Teladoc's ability to make the Livongo deal work for investors and surpass lofty analyst expectations.
For further details see:
4 Reasons Teladoc Health Stock Can Reach $305